Consumption of Meat, Fish, Dairy Products, and Eggs and Risk of Ischemic Heart Disease.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
18 06 2019
Historique:
pubmed: 23 4 2019
medline: 24 3 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

There is uncertainty about the relevance of animal foods to the pathogenesis of ischemic heart disease (IHD). We examined meat, fish, dairy products, and eggs and risk for IHD in the pan-European EPIC cohort (European Prospective Investigation Into Cancer and Nutrition). In this prospective study of 409 885 men and women in 9 European countries, diet was assessed with validated questionnaires and calibrated with 24-hour recalls. Lipids and blood pressure were measured in a subsample. During a mean of 12.6 years of follow-up, 7198 participants had a myocardial infarction or died of IHD. The relationships of animal foods with risk were examined with Cox regression with adjustment for other animal foods and relevant covariates. The hazard ratio (HR) for IHD was 1.19 (95% CI, 1.06-1.33) for a 100-g/d increment in intake of red and processed meat, and this remained significant after exclusion of the first 4 years of follow-up (HR, 1.25 [95% CI, 1.09-1.42]). Risk was inversely associated with intakes of yogurt (HR, 0.93 [95% CI, 0.89-0.98] per 100-g/d increment), cheese (HR, 0.92 [95% CI, 0.86-0.98] per 30-g/d increment), and eggs (HR, 0.93 [95% CI, 0.88-0.99] per 20-g/d increment); the associations with yogurt and eggs were attenuated and nonsignificant after exclusion of the first 4 years of follow-up. Risk was not significantly associated with intakes of poultry, fish, or milk. In analyses modeling dietary substitutions, replacement of 100 kcal/d from red and processed meat with 100 kcal/d from fatty fish, yogurt, cheese, or eggs was associated with ≈20% lower risk of IHD. Consumption of red and processed meat was positively associated with serum non-high-density lipoprotein cholesterol concentration and systolic blood pressure, and consumption of cheese was inversely associated with serum non-high-density lipoprotein cholesterol. Risk for IHD was positively associated with consumption of red and processed meat and inversely associated with consumption of yogurt, cheese, and eggs, although the associations with yogurt and eggs may be influenced by reverse causation bias. It is not clear whether the associations with red and processed meat and cheese reflect causality, but they were consistent with the associations of these foods with plasma non-high-density lipoprotein cholesterol and for red and processed meat with systolic blood pressure, which could mediate such effects.

Sections du résumé

BACKGROUND
There is uncertainty about the relevance of animal foods to the pathogenesis of ischemic heart disease (IHD). We examined meat, fish, dairy products, and eggs and risk for IHD in the pan-European EPIC cohort (European Prospective Investigation Into Cancer and Nutrition).
METHODS
In this prospective study of 409 885 men and women in 9 European countries, diet was assessed with validated questionnaires and calibrated with 24-hour recalls. Lipids and blood pressure were measured in a subsample. During a mean of 12.6 years of follow-up, 7198 participants had a myocardial infarction or died of IHD. The relationships of animal foods with risk were examined with Cox regression with adjustment for other animal foods and relevant covariates.
RESULTS
The hazard ratio (HR) for IHD was 1.19 (95% CI, 1.06-1.33) for a 100-g/d increment in intake of red and processed meat, and this remained significant after exclusion of the first 4 years of follow-up (HR, 1.25 [95% CI, 1.09-1.42]). Risk was inversely associated with intakes of yogurt (HR, 0.93 [95% CI, 0.89-0.98] per 100-g/d increment), cheese (HR, 0.92 [95% CI, 0.86-0.98] per 30-g/d increment), and eggs (HR, 0.93 [95% CI, 0.88-0.99] per 20-g/d increment); the associations with yogurt and eggs were attenuated and nonsignificant after exclusion of the first 4 years of follow-up. Risk was not significantly associated with intakes of poultry, fish, or milk. In analyses modeling dietary substitutions, replacement of 100 kcal/d from red and processed meat with 100 kcal/d from fatty fish, yogurt, cheese, or eggs was associated with ≈20% lower risk of IHD. Consumption of red and processed meat was positively associated with serum non-high-density lipoprotein cholesterol concentration and systolic blood pressure, and consumption of cheese was inversely associated with serum non-high-density lipoprotein cholesterol.
CONCLUSIONS
Risk for IHD was positively associated with consumption of red and processed meat and inversely associated with consumption of yogurt, cheese, and eggs, although the associations with yogurt and eggs may be influenced by reverse causation bias. It is not clear whether the associations with red and processed meat and cheese reflect causality, but they were consistent with the associations of these foods with plasma non-high-density lipoprotein cholesterol and for red and processed meat with systolic blood pressure, which could mediate such effects.

Identifiants

pubmed: 31006335
doi: 10.1161/CIRCULATIONAHA.118.038813
pmc: PMC6629175
doi:

Substances chimiques

Biomarkers 0
Cholesterol, HDL 0

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2835-2845

Subventions

Organisme : Medical Research Council
ID : MR/L003120/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0700463
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205212/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 570/A16491
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 25004
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/08/014
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Department of Health
ID : IS-BRC-1215-20014
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/09/002
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800270
Pays : United Kingdom

Références

Blood Press Monit. 2002 Apr;7(2):95-104
pubmed: 12048426
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Public Health Nutr. 2002 Dec;5(6B):1125-45
pubmed: 12639223
Eur J Epidemiol. 2007;22(2):129-41
pubmed: 17295097
Lancet. 2007 Dec 1;370(9602):1829-39
pubmed: 18061058
Int J Epidemiol. 2008 Apr;37(2):368-78
pubmed: 18180242
Br J Nutr. 2009 Nov;102(9):1267-75
pubmed: 19682399
JAMA. 2009 Nov 11;302(18):1993-2000
pubmed: 19903920
Am J Clin Nutr. 2011 Jan;93(1):158-71
pubmed: 21068345
Br J Nutr. 2011 Jun 28;105(12):1823-31
pubmed: 21281532
Public Health Nutr. 2012 Apr;15(4):725-37
pubmed: 21914258
Eur J Epidemiol. 2012 Jan;27(1):15-25
pubmed: 22089423
Curr Atheroscler Rep. 2012 Dec;14(6):515-24
pubmed: 23001745
BMJ. 2013 Jan 07;346:e8539
pubmed: 23295181
Nat Med. 2013 May;19(5):576-85
pubmed: 23563705
Ann Intern Med. 2014 Mar 18;160(6):398-406
pubmed: 24723079
Br J Nutr. 2014 Sep 14;112(5):762-75
pubmed: 24932617
Eur J Epidemiol. 2015 Jan;30(1):57-70
pubmed: 25377533
Asia Pac J Clin Nutr. 2015;24(1):90-100
pubmed: 25740747
Lancet Oncol. 2015 Dec;16(16):1599-600
pubmed: 26514947
J Hypertens. 2016 Sep;34(9):1721-9
pubmed: 27379533
JAMA Intern Med. 2016 Oct 1;176(10):1453-1463
pubmed: 27479196
Eur J Nutr. 2017 Dec;56(8):2565-2575
pubmed: 27517544
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
Nutr Res Rev. 2016 Dec;29(2):249-267
pubmed: 27666526
Eur J Clin Nutr. 2017 May;71(5):573-579
pubmed: 27804959
Eur J Clin Nutr. 2018 Jan;72(1):44-56
pubmed: 28952608
Eur J Epidemiol. 2018 Feb;33(2):137-140
pubmed: 29478107
Heart. 2018 Nov;104(21):1756-1763
pubmed: 29785957
Lancet. 2018 Nov 24;392(10161):2288-2297
pubmed: 30217460
BMJ. 1997 Jan 11;314(7074):112-7
pubmed: 9006469

Auteurs

Timothy J Key (TJ)

Nuffield Department of Population Health, University of Oxford, United Kingdom (T.J.K., P.N.A., K.E.B.).

Paul N Appleby (PN)

Nuffield Department of Population Health, University of Oxford, United Kingdom (T.J.K., P.N.A., K.E.B.).

Kathryn E Bradbury (KE)

Nuffield Department of Population Health, University of Oxford, United Kingdom (T.J.K., P.N.A., K.E.B.).
National Institute for Health Innovation, School of Population Health, University of Auckland, New Zealand (K.E.B.).

Michael Sweeting (M)

Medical Research Council/British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, United Kingdom (M. Sweeting, A.W., E.d.A., A.B., J.D.).

Angela Wood (A)

Medical Research Council/British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, United Kingdom (M. Sweeting, A.W., E.d.A., A.B., J.D.).

Ingegerd Johansson (I)

Department of Odontology, Umeå University, Sweden (I.J.).

Tilman Kühn (T)

German Cancer Research Center, Division of Cancer Epidemiology, Heidelberg (T.K., V. Katzke).

Marinka Steur (M)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, United Kingdom (M. Steur, C.L., N.F., N.W.).

Elisabete Weiderpass (E)

Department of Community Medicine, Faculty of Health Sciences, Universitetet i Tromsø, Arctic University of Norway, Tromsø (E.W., G.S.).
Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo (E.W.).
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (E.W.).
Genetic Epidemiology Group, Folkhälsan Research Center, and Faculty of Medicine, University of Helsinki, Finland (E.W.).

Maria Wennberg (M)

Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Sweden (M.W.).

Anne Mette Lund Würtz (AM)

Section for Epidemiology, Department of Public Health, Aarhus University, Denmark (A.M.L.W., K.O.).

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-Institut d'Investigació Biomédica de Bellvitge, Barcelona, Spain (A.A.).

Jonas Andersson (J)

Department of Public Health and Clinical Medicine, Research Unit Skellefteå, Umeå University, Sweden (J.A.).

Larraitz Arriola (L)

Public Health Division of Gipuzkoa, Instituto BIO-Donostia, Basque Government, San Sebastian, Spain (L.A.).
CIBER (Biomedical Research Networking Centres) de Epidemiología y Salud Pública, Madrid, Spain (L.A., J.M.H.).

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition (DIfE), Potsdam-Rehbrücke (H.B.).

Jolanda M A Boer (JMA)

Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands (J.M.A.B.).

Fabrice Bonnet (F)

CESP, INSERM (Centre de recherche en Epidémiologie et Santé des Populations, Institut national de la santé et de la recherche médicale) U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif Cedex, France (F.B., M.-C.B.-R., G.F.).
Gustave Roussy, Villejuif Cedex, Paris, France (F.B., M.-C.B.-R., G.F.).
Department of Endocrinology, Rennes University Hospital (CHU), France (F.B.).
Rennes 1 University, France (F.B.).

Marie-Christine Boutron-Ruault (MC)

CESP, INSERM (Centre de recherche en Epidémiologie et Santé des Populations, Institut national de la santé et de la recherche médicale) U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif Cedex, France (F.B., M.-C.B.-R., G.F.).
Gustave Roussy, Villejuif Cedex, Paris, France (F.B., M.-C.B.-R., G.F.).

Amanda J Cross (AJ)

School of Public Health, Imperial College, London, United Kingdom (A.J.C., E.R.).

Ulrika Ericson (U)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden (U.E., E.S.).

Guy Fagherazzi (G)

CESP, INSERM (Centre de recherche en Epidémiologie et Santé des Populations, Institut national de la santé et de la recherche médicale) U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif Cedex, France (F.B., M.-C.B.-R., G.F.).
Gustave Roussy, Villejuif Cedex, Paris, France (F.B., M.-C.B.-R., G.F.).

Pietro Ferrari (P)

International Agency for Research on Cancer, World Health Organization, Lyon, France (P.F., M.G., M. Stepien).

Marc Gunter (M)

International Agency for Research on Cancer, World Health Organization, Lyon, France (P.F., M.G., M. Stepien).

José María Huerta (JM)

Department of Epidemiology, Murcia Regional Health Council, IMIB (Instituto Murciano de Investigación Biosanitaria)-Arrixaca, Spain (J.M.H.).

Verena Katzke (V)

German Cancer Research Center, Division of Cancer Epidemiology, Heidelberg (T.K., V. Katzke).

Kay-Tee Khaw (KT)

Clinical Gerontology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, United Kingdom (K.-T.K.).

Vittorio Krogh (V)

Epidemiology and Prevention Unit, Fondazione IRCCS (Institute for Research, Hospitalization and Health Care) Istituto Nazionale dei Tumori, Milan, Italy (V. Krogh).

Carlo La Vecchia (C)

Hellenic Health Foundation, Athens, Greece (C.L.V., A. Trichopoulou).
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy (C.L.V.).

Giuseppe Matullo (G)

Italian Institute for Genomic Medicine, Turin (G.M.).
Department of Medical Sciences, University of Turin, Italy (G.M.).

Conchi Moreno-Iribas (C)

Instituto de Salud Pública de Navarra, IdiSNA-Navarre Institute for Health Research, Pamplona, Spain (C.M.-I.).

Androniki Naska (A)

World Health Organization Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece (A.N., A. Trichopoulou).

Lena Maria Nilsson (LM)

Arctic Research Center at Umeå University, Sweden (L.M.N.).

Anja Olsen (A)

Danish Cancer Society Research Center, Copenhagen, Denmark (A.O., A.Tjønneland).

Kim Overvad (K)

Section for Epidemiology, Department of Public Health, Aarhus University, Denmark (A.M.L.W., K.O.).

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy (D.P.).

Salvatore Panico (S)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy (S.P.).

Elena Molina-Portillo (E)

Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria, Universidad de Granada, Spain (E.M.-P.).

J Ramón Quirós (JR)

Public Health Directorate of Asturias, Oviedo, Spain (J.R.Q.).

Guri Skeie (G)

Department of Community Medicine, Faculty of Health Sciences, Universitetet i Tromsø, Arctic University of Norway, Tromsø (E.W., G.S.).

Ivonne Sluijs (I)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands (I.S., Y.T.v.d.S., W.M.M.V.).

Emily Sonestedt (E)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden (U.E., E.S.).

Magdalena Stepien (M)

International Agency for Research on Cancer, World Health Organization, Lyon, France (P.F., M.G., M. Stepien).

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark (A.O., A.Tjønneland).

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece (C.L.V., A. Trichopoulou).
World Health Organization Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece (A.N., A. Trichopoulou).

Rosario Tumino (R)

Cancer Registry and Histopathology Unit, "Civic-M.p.Arezzo" Hospital, ASP (Azienda Sanitaria Provinciale) Ragusa, Italy (R.T.).

Ioanna Tzoulaki (I)

Department of Epidemiology and Biostatistics (I.T.), School of Public Health, Imperial College London, United Kingdom.
Medical Research Council-Public Health England Centre for Environment (I.T.), School of Public Health, Imperial College London, United Kingdom.
Department of Hygiene and Epidemiology, University of Ioannina Medical School, Greece (I.T.).

Yvonne T van der Schouw (YT)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands (I.S., Y.T.v.d.S., W.M.M.V.).

W M Monique Verschuren (WMM)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands (I.S., Y.T.v.d.S., W.M.M.V.).

Emanuele di Angelantonio (E)

Medical Research Council/British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, United Kingdom (M. Sweeting, A.W., E.d.A., A.B., J.D.).

Claudia Langenberg (C)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, United Kingdom (M. Steur, C.L., N.F., N.W.).

Nita Forouhi (N)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, United Kingdom (M. Steur, C.L., N.F., N.W.).

Nick Wareham (N)

Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, United Kingdom (M. Steur, C.L., N.F., N.W.).

Adam Butterworth (A)

Medical Research Council/British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, United Kingdom (M. Sweeting, A.W., E.d.A., A.B., J.D.).

Elio Riboli (E)

School of Public Health, Imperial College, London, United Kingdom (A.J.C., E.R.).

John Danesh (J)

Medical Research Council/British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, United Kingdom (M. Sweeting, A.W., E.d.A., A.B., J.D.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH